Role of pretrial systemic opioid requirements, intrathecal trial dose, and non-psychological factors as predictors of outcome for intrathecal pump therapy: One clinician's experience with lumbar postlaminectomy pain

Neuromodulation

Volumn 14, Issue 2, 2011, Pages 165-175

  Kim, David ^a   Saidov, Alik ^a   Mandhare, Vijay ^a   Shuster, Adam ^a   Kim, David Daewhan ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Chronic pain; Intrathecal drug delivery; Intrathecal pump; Low back pain; Nonmalignant pain; Outcomes; Patient selection; Programmable pump; Retrospective study; Trial; Ziconotide

Indexed keywords

BUPIVACAINE; CLONIDINE; FENTANYL; HYDROMORPHONE; METHADONE; MORPHINE; OMEGA CONOTOXIN MVIIA; OPIATE;

ADULT; AGED; ANALGESIA; ARTICLE; BACKACHE; CLINICAL ARTICLE; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; FAILED BACK SURGERY SYNDROME; FEMALE; GENDER; HUMAN; LEG PAIN; LONG TERM CARE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PAIN PARAMETERS; PAIN THRESHOLD; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SUSTAINED DRUG RELEASE; THORACOLUMBAR SPINE; VISUAL ANALOG SCALE; ALGORITHM; CLINICAL PRACTICE; HOSPITAL; IMPLANT; NOTE; PROSPECTIVE STUDY; DRUG EFFICACY;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; CHRONIC PAIN; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, SPINAL; LOW BACK PAIN; MALE; MIDDLE AGED; PAIN MEASUREMENT; PATIENT SELECTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79953741773     PISSN: 10947159     EISSN: 15251403     Source Type: Journal    
DOI: 10.1111/j.1525-1403.2011.00333.x     Document Type: Article

References (74)

1. Krames ES. Spinal administration of opioids and other analgesic compounds. In: Waldman SD, ed. Interventional Pain Management. Philadelphia: W.B. Saunders, 2001:593-603.
2. Stearns L, Boortz-Marx R, Du Pen S et al. Intrathecal drug delivery for management of cancer pain. J Support Oncol 2005;3:399-408.
3. Krames ES, Olson K. Clinical realities and economic considerations: patient selection in intrathecal therapy. J Pain Symptom Manage 1997;14 (Suppl.):S3-S13. (Pubitemid 27377603)
4. Winkelmuller M, Winkmuller W. Long term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg 1996;85:458-467. (Pubitemid 26278029)
5. Paice JA, Penn RD, Shott S. Intraspinal morphine for chronic pain: a retrospective multicenter study. J Pain Symptom Manage 1996;11:71-80. (Pubitemid 26073492)
6. Follet KA, Hitchon PW, Piper J et al. Response of intrathecal morphine: a retrospective study. Pain 1992;49:21-25.
7. Nitescu P, Dahm P, Applegren L et al. Continuous infusion of opioid and bupivacaine by externalized catheters in long tern treatment of "refractory" nonmalignant pain. Clin J Pain 1998;14:17-28.
8. Thimineur MA, Kravitz E, Vodapally MS. Intrathecal opioid treatment for chronic non-malignant pain: a 3 year prospective study. Pain 2004;109:242-249. (Pubitemid 38638700)
9. Deer T, Chapple I, Classen A et al. Intrathecal drug delivery for treatment of chronic low back pain: report from the National Outcomes Registry for Low Back Pain. Pain Med 2004;5:6-13. (Pubitemid 38404439)
10. Kumar K, Kelly M, Pirlot T. Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: long term benefits and efficacy. Surg Neurol 2001;55:79-86. (Pubitemid 32297679)
11. Corrado P, Alperson B, Wright M. Perceived success and failure of intrathecal pump implantation in chronic pain patients. Neuromodulation 2008;11:98-102. (Pubitemid 351490211)
12. Smith TJ, Statts PS, Deer T et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol 2005;8:736-742. (Pubitemid 41266249)
13. Prager JP. Neuroaxial medication delivery: the development and maturity of a concept for treating chronic pain of spinal origin. Spine 2002;27:2593-2605.
14. Krames E. Implantable devices for pain control: spinal cord stimulation and intrathecal therapies. Best Pract Res Clin Anaesthesiol 2002;16:619-649. (Pubitemid 38937106)
15. Caudill MA, Holman GH, Turk D. Effective ways to manage chronic pain. Patient Care 1996;31:154-166.
16. Rainov NG, Heidecke V, Burkert W. Long term intrathecal infusion of drug combinations for chronic back and leg pain. J Pain Symptom Manage 2001;22:862-871. (Pubitemid 32884379)
17. Anderson V, Burchiel KJ. A prospective study of long term intrathecal morphine in the management of chronic nonmalignant pain. Neurosurgery 1999;44:289-301. (Pubitemid 29068172)
18. Hassenbush S, Buchiel K, Coffey RJ et al. Management of intrathecal catheter-tip inflammatory masses: a consensus statement. Pain Med 2002;3:313-323. (Pubitemid 36040733)
19. Peng P, Massicotte EM. Spinal cord compression from intrathecal catheter tip inflammatory mass: case report and a review of etiology. Reg Anesth Pain Med 2004;29:237-242. (Pubitemid 38685821)
20. Hassenbusch SJ, Portenoy R, Cousins M et al. Polyanalgesic consensus conference: an update on the management of pain by intraspinal drug delivery-report of an expert panel. J Pain Symptom Manage 2004;27:540-563. (Pubitemid 38686413)
21. Deer T, Krames E, Hassenbusch S et al. Management of intrathecal catheter-tip inflammatory masses:an updated 2007 consensus statement froman expert panel. Neuromodulation 2008;11:71-91.
22. Parkinson SK, Bailey SL, Little WL et al. Myoclonic seizure activity with chronic high-dose spinal opioid administration. Anaesthesiology 1990;72:743-745. (Pubitemid 20114723)
23. Dominguez E, Sahinler B, Bassam D et al. Predictive value of intrathecal narcotic trials for long-term therapy with implantable drug administration systems in chronic non-cancer pain. Pain Pract 2002;2:315-325.
24. Prager J, Jacobs M. Evaluation of patients for implantable pain modalities: medical and behavioral assessment. Clin J Pain 2001;17:206-214. (Pubitemid 32906539)
25. Peng P, Federoff I, Jaques L et al. Survey of the practice of spinal cord stimulators and intrathecal analgesic delivery implants for management in Canada. Pain Res Manage 2007;12:281-285. (Pubitemid 351255913)
26. Tutak U, Doleys DM. Intrathecal infusion systems for treatment of chronic low back pain and leg pain of noncancer origin. South Med J 1996;89:295-300. (Pubitemid 26075251)
27. Angel IF, Gould HJ Jr, Carey ME. Intrathecal morphine pumps as a treatment option in chronic pain of nonmalignant origin. Surg Neurol 1998;49:92-98; discussion 98-99.
28. Levy RM. Quantitative crossover, double-blind trial paradigm for patient screening for chronic intraspinal narcotic administration. Neurosurg Focus 1997;2:e2.
29. Maniker AH, Kreiger AJ, Adler RJ et al. Epidural trial in implantation of intrathecal morphine infusion pumps. N J Med 1991;88:797-801.
30. Krames ES. Intraspinal opioid therapy for chronic nonmalignant pain: current practice and clinical guidelines. J Pain Symptom Manage 1996;11:333-352. (Pubitemid 26157413)
31. Krames ES. Intrathecal infusion therapies for intractable pain: patient management guidelines. J Pain Symptom Manage 1993;8:36-46. (Pubitemid 23060184)
32. Roberts LJ, Finch PM, Goucke CR et al. Outcome of intrathecal opioids in chronic non-cancer pain. Eur J Pain 2001;5:353-361. (Pubitemid 34072462)
33. Shaladi A, Saltari MR, Piva B et al. Continuous intrathecal morphine infusion in patients with vertebral fractures due to osteoporosis. Clin J Pain 2007;23:511-517. (Pubitemid 46956188)
34. Gestin Y, Vaino A, Peguier AM. Long-term intrathecal infusion of morphine in the home care of patients with advanced cancer. Acta Anaesthesiol Scand 1997;41:12-17. (Pubitemid 27077144)
35. Onofrio BM, Yaksh TL. Long-term pain relief produced by intrathecal morphine infusion in 53 patients. J Neurosurg 1990;72:200-209. (Pubitemid 20087708)
36. Ashcroft GS, Mills SJ, Ashworth JJ. Ageing and wound healing. Biogerontology 2002;3:337-345.
37. Choi SJ, Harii K, Lee MJ et al. Electrophysiological, morphological, morphometric effects of aging on nerve regeneration in rats. Scand J Plast Reconstr Surg Hand Surg 1995;29:133-140.
38. Crisp Y Giles JR, Cruse WL et al. The effects of aging on thermal hyperalgesia and tactile-evoked allodynia using two models of peripheral mononeuropathy in the rat. Neurosci Lett 2003;339:103-106.
39. Novak JC, Lowell JA, Stuesse SL et al. Aging and neuropathicpain. Brain Res 1999;833:308-310.
40. Stuesse SL, Crisp T, McBurney DL et al. Neuropathic pain in aged rats: behavioral responses and astrocyte activation. Exp Brain Res 2002;137:219-227.
41. Edward RR, Fillingim RB. Effects of age on temporal summation of thermal pain: clinical relevance in healthy older and younger adults. J Pain 2003;101:155-165.
42. Zheng Z, Gibson SJ, Khalil Z et al. Age-related differences in the time course of capsaicin-induced hyperalgesia. Pain 2000;85:51-58. (Pubitemid 30110743)
43. Dworkin RH, Harstein G, Rosner HL et al. A high risk method for studying psychosocial antecedents of chronic pain: the prospective investigation of herpes zoster. J Abnorm Psychol 1992;101:200-205.
44. Turk DC, Okifuji A, Scharff L et al. Chronic pain and depression: role of perceived impact and perceived control in different age cohorts. Pain 1995;61:93-101.
45. Kremer E, Atkinson JH, Ignelzi RJ. Measurement of pain: patient preference does not confound pain measurement. Pain 1981;10:241-249.
46. Gagliese L, Melzack R. Age differences in the quality of chronic pain: a preliminary study. Pain Res Manage 1997;2:157-162. (Pubitemid 127734988)
47. Herr KA, Mobily PR. Comparison of selected pain assessment tools for use with elderly. Appl Nurs Res 1993;6:39-46.
48. Bingefor K, Isacson D. Epidemiology, comorbidity, and impact on health-related quality of life of self reported headache and musculoskeletal pain. A gender perspective. Eur J Pain 2004;8:435-450. (Pubitemid 39485768)
49. Ihlebaek C, Hansson TH, Laerum E et al. Prevalence of low back pain and sickness abcense: a "borderline" study in Norway and Sweden. Scand J Public Health 2006;34:555-558.
50. Schneider S, Randoll D, Buchner M. Why do women have back pain more than men? A representative prevalence study in the federal republic of Germany. Clin J Pain 2006;22:738-747. (Pubitemid 44434958)
51. Thomas E, Silman AJ, Croft PR et al. Predicting who develops chronic low back pain in primary care: a prospective study. BMJ 1999;318:1662-1667. (Pubitemid 29276761)
52. Smith BH, Elliot AM, Chambers WA et al. The impact of chronic pain in the community. Fam Pract 2001;18:292-299.
53. Aubrun F, Salvi N, Coriat P et al. Sex and age-related differences in morphine requirements for post operative pain relief. Anesthesiology 2005;103:156-160. (Pubitemid 40943148)
54. Bijur PE, Esses D, Birnbaum A, Chang AK. Response to morphine in male and female patients: analgesia and adverse events. Clin J Pain 2008;24:192-198. (Pubitemid 351640915)
55. Cepeda MS, Carr DB. Women experience more pain and require more morphine that men to achieve a similar degree of analgesia. Anesth Analg 2003;97:1464-1468. (Pubitemid 37310148)
56. Chia YY, Chow LH, Hung CC et al. Gender and pain upon movement are associated with the requirements formpostoperative patient-controlled IV analgesia: a prospective survey of 2298 Chinese patients. Can J Anaesth 2002;49:249-255.
57. Hirasawa M, Hasegawa J, Nishiyama J et al. Utilization of PCIA (patient-controlled intravenous analgesia) for postoperative analgesia of spine fusion. Tokai J Exp Clin Med 2003;28:17-20. (Pubitemid 36834503)
58. Fillingim RB, Ness TJ, Glover TL et al. Morphine responses and experimental pain: sex differences in side effects and cardiovascular responses and not analgesia. J Pain 2005;6:116-124. (Pubitemid 40203048)
59. Olofsen E, Romberg R, Bijl H et al. Alfentil and placebo analgesia: no sex differences detected in models of experimental pain. Anesthesiology 2005;103:130-139. (Pubitemid 40943145)
60. Pud D, Yarnitsky D, Sprecher E et al. Can personality traits and gender predict response to morphine? An experimental cold pain study. Eur J Pain 2006;10:103-112. (Pubitemid 41727761)
61. Eisenberg E, McNichol ED, Carr DB. Opioids for neuopathic pain. Cochrane Database Syst Rev 2009; issue 3: CD006146.
62. Khoromi S, Cui L, Nackers L et al. Morphine, nortriptyline, and their combination versus placedo in patients with chronic lumbar root pain. Pain 2007;130:65-75.
63. Becker R, Jakob D, Uhle EI et al. The significance of intrathecal opioid therapy for treatment of neuropathic cancer pain conditions. Stereotact Funct Neurosurg 2000;75:16-26.
64. Hassenbusch SJ, Stanton Hicks M, Covington EC. Long-term intraspinal infusions of opioids in the treatment of neuropathic pain. J Pain Symptom Manage 1995;10:527-543.
65. Krames ES, Lanning RM. Inrathecal infusion analgesic efficacy of intrathecal opioid with and without bupivacaine. J Pain Symptom Manage 1993;8:539-548. (Pubitemid 24003058)
66. Sjoberg M, Nitescu P, Appelgren L et al. Long termintrathecal morphine and bupivacaine in patients with refractory cancer pain. Anesthesiology 1994;80:284-297.
67. Uhle EI, Becker R, Gatscher S et al. Continuous intrathecal clonidine adminstration for the treatment of neuropathic pain. Stereotact Funct Neurosurg 2000;75:167-175. (Pubitemid 34702080)
68. Akerman LL, Follett KA, Rosenquist RW. Long-term outcomes during treatment of chronic pain with clonidine or clonidine/opioid combinations. J Pain Symptom Manage 2003;26:668-677. (Pubitemid 36802290)
69. Bejune K, Stubhaug A, Dodgson MS et al. Additive analgesic effect of codiene and paracetamol can be detected in strong, but not moderate pain after caesarean section. Acta Anaesthesiol Scand 1998;40:399-407.
70. Brevik EK, Barkvoll P, Skovlunde E. Combining ciclofenac with acetominophen-codiene after oral surgery: a randomized double-blind single dose study. Clin Pharmacol Ther 1999;6:624-635.
71. Kalso E, Simpson KH, Slappendel R et al. Predicting long-term response to strong opioids in patientswith lowback pain:finding from a randomized controlled trial of transdermal fentanyl and morphine. BMC Med 2007;5:1-8.
72. Dufton J, Kopec J, Wong H et al. Prognostic factors associated with minimal improvement following acute whiplash-associated disorder. Spine 2006;31:759-765.
73. Scicchitano J, Rounsefell B. PilowskyBaseline correlates of the response to the treatment of chronic localized myofascial pain syndrome by injection of local anaesthetic. J Psychosom Res 1996;40:75-85.
74. Deer T, Krames E, Hassenbusch SJ et al. Polyanalgesic consensus conference 2007: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel. Neuromodulation 2007;10:300-328.